MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

StemCells Company Profile (NASDAQ:STEM)

Consensus Ratings for StemCells (NASDAQ:STEM) (?)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $2.21 (437.71% upside)

Analysts' Ratings History for StemCells (NASDAQ:STEM)
Show:
DateFirmActionRatingPrice TargetActions
7/21/2015Maxim GroupReiterated RatingBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/22/2015Cantor FitzgeraldReiterated RatingBuy$2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/21/2015Cantor FitzgeraldInitiated CoverageBuy$2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/18/2015Maxim GroupReiterated RatingBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/18/2015HC WainwrightInitiated CoverageBuy$1.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/11/2015Chardan CapitalLower Price TargetBuy$2.25 -> $1.55View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015Ascendiant Capital MarketsReiterated RatingBuy$1.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/26/2015Chardan CapitalInitiated CoverageBuy$2.25View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/22/2014Maxim GroupSet Price TargetBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/7/2014Maxim GroupInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/2/2014Brinson PatrickInitiated CoverageOutperform$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/20/2014Maxim GroupBoost Price TargetBuy$2.50 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/17/2014Chardan CapitalReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2014Maxim GroupReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/17/2014Edison Investment ResearchNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/2/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha